A comprehensive custom panel evaluation for routine hereditary cancer testing: improving the yield of germline mutation detection

In the context of our Regional Program of Hereditary Cancer, individuals fulfilling the criteria are tested for germline mutations to subsequently establish the clinical management. Our standard diagnostic app...

Source: Journal of Translational Medicine - June 10, 2020 Category: Research Authors: Carolina Vel ázquez, Enrique Lastra, Francisco Avila Cobos, Luis Abella, Virginia de la Cruz, Blanca Ascensión Hernando, Lara Hernández, Noemí Martínez, Mar Infante and Mercedes Durán Tags: Research Source Type: research